[
    [
        {
            "time": "2021-10-28",
            "original_text": "Regeneron (REGN) Releases Initial Data on Cocktail for COVID-19",
            "features": {
                "keywords": [
                    "Regeneron",
                    "REGN",
                    "Cocktail",
                    "COVID-19",
                    "Initial Data"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "Regeneron (REGN) Releases Initial Data on Cocktail for COVID-19",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "Regeneron’s Antibodies Appear to Help Hospitalized Patients—and Could Help 2021 Revenue",
            "features": {
                "keywords": [
                    "Regeneron’s Antibodies",
                    "Hospitalized Patients",
                    "2021 Revenue"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Regeneron’s Antibodies Appear to Help Hospitalized Patients—and Could Help 2021 Revenue",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]